0000000000710016

AUTHOR

Clara Mayo De Las Casas

showing 1 related works from this author

EGFR mutant cfDNA and CTC detection as biomarkers in patients diagnosed with advanced non-small cell lung cancer.

2016

e23039Background: One of the most promising developments in translational cancer has been the emergence of liquid biopsy as a non-invasive biomarker. CTCs and cfDNA offer valuable prognostic and pr...

Cancer Researchbusiness.industryMutantCancermedicine.diseaseOncologyCancer researchMedicineBiomarker (medicine)In patientNon small cellLiquid biopsybusinessLung cancerJournal of Clinical Oncology
researchProduct